These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 28795272)
1. PET Imaging on Dynamic Metabolic Changes after Combination Therapy of Paclitaxel and the Traditional Chinese Medicine in Breast Cancer-Bearing Mice. Chen Y; Wang L; Liu H; Song F; Xu C; Zhang K; Chen Q; Wu S; Zhu Y; Dong Y; Zhou M; Zhang H; Tian M Mol Imaging Biol; 2018 Apr; 20(2):309-317. PubMed ID: 28795272 [TBL] [Abstract][Full Text] [Related]
3. [ Lu Y; Li M; Massicano AVF; Song PN; Mansur A; Heinzman KA; Larimer BM; Lapi SE; Sorace AG Molecules; 2021 Mar; 26(6):. PubMed ID: 33809310 [TBL] [Abstract][Full Text] [Related]
4. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice. McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567 [TBL] [Abstract][Full Text] [Related]
5. 18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy. Sun X; Yan Y; Liu S; Cao Q; Yang M; Neamati N; Shen B; Niu G; Chen X J Nucl Med; 2011 Jan; 52(1):140-6. PubMed ID: 21149494 [TBL] [Abstract][Full Text] [Related]
6. [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer. Raccagni I; Belloli S; Valtorta S; Stefano A; Presotto L; Pascali C; Bogni A; Tortoreto M; Zaffaroni N; Daidone MG; Russo G; Bombardieri E; Moresco RM PLoS One; 2018; 13(5):e0197754. PubMed ID: 29791503 [TBL] [Abstract][Full Text] [Related]
7. Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts. Kristian A; Revheim ME; Qu H; Mælandsmo GM; Engebråten O; Seierstad T; Malinen E Acta Oncol; 2013 Oct; 52(7):1566-72. PubMed ID: 23984812 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of folate targeted biodegradable polymer-paclitaxel conjugate micelles on EMT-6 breast cancer model. Wu D; Zheng Y; Hu X; Fan Z; Jing X Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():68-75. PubMed ID: 26042692 [TBL] [Abstract][Full Text] [Related]
9. Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET. Munk Jensen M; Erichsen KD; Björkling F; Madsen J; Jensen PB; Sehested M; Højgaard L; Kjær A PLoS One; 2013; 8(12):e85126. PubMed ID: 24386456 [TBL] [Abstract][Full Text] [Related]
10. Liu H; Sun H; Zhang B; Liu S; Deng S; Weng Z; Zuo B; Yang J; He Y Breast Cancer; 2020 May; 27(3):372-380. PubMed ID: 31781983 [TBL] [Abstract][Full Text] [Related]
11. Glucose-6-phosphatase Expression-Mediated [ Kim MJ; Lee CH; Lee Y; Youn H; Kang KW; Kwon J; Alavi A; Carlin S; Cheon GJ; Chung JK Mol Imaging Biol; 2019 Oct; 21(5):917-925. PubMed ID: 30719695 [TBL] [Abstract][Full Text] [Related]
12. Huaier extract enhances the treatment efficacy of paclitaxel in breast cancer cells via the NF-κB/IκBα pathway. Yang L; Song Z; Wang X; Yang W; Wang M; Liu H Oncol Rep; 2017 Dec; 38(6):3455-3464. PubMed ID: 29039556 [TBL] [Abstract][Full Text] [Related]
13. Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling. Cooper AC; Fleming IN; Phyu SM; Smith TA J Cancer Res Clin Oncol; 2015 Sep; 141(9):1523-32. PubMed ID: 25579456 [TBL] [Abstract][Full Text] [Related]
14. Targeting claudin-4 enhances chemosensitivity in breast cancer. Luo Y; Kishi S; Sasaki T; Ohmori H; Fujiwara-Tani R; Mori S; Goto K; Nishiguchi Y; Mori T; Kawahara I; Kondoh M; Kuniyasu H Cancer Sci; 2020 May; 111(5):1840-1850. PubMed ID: 32086991 [TBL] [Abstract][Full Text] [Related]
15. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice. McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760 [TBL] [Abstract][Full Text] [Related]
16. Effects of WD‑3 on tumor growth and the expression of integrin αvβ3 and ERK1/2 in mice bearing human gastric cancer using the 18F‑RGD PET/CT imaging system. Jin C; Zhang BN; Wei Z; Ma B; Pan Q; Hu P Mol Med Rep; 2017 Dec; 16(6):9295-9300. PubMed ID: 29152665 [TBL] [Abstract][Full Text] [Related]
17. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer. Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263 [TBL] [Abstract][Full Text] [Related]
18. The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts. Milanović D; Braun F; Weber W; Grosu AL; Behe M; Niedermann G BMC Cancer; 2012 Jun; 12():242. PubMed ID: 22695475 [TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography. Nielsen CH; Jensen MM; Kristensen LK; Dahlman A; Fröhlich C; Jacobsen HJ; Poulsen TT; Lantto J; Horak ID; Kragh M; Kjaer A Oncotarget; 2015 Nov; 6(35):37486-99. PubMed ID: 26460961 [TBL] [Abstract][Full Text] [Related]
20. A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer. Aliaga A; Rousseau JA; Cadorette J; Croteau E; van Lier JE; Lecomte R; Bénard F Mol Imaging Biol; 2007; 9(3):144-50. PubMed ID: 17334852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]